Explore the latest in esophageal disease, including motility disorders, diagnosis, and management of Barrett’s esophagus and esophageal cancer.
This randomized clinical trial compares the efficacy and safety of simultaneous integrated boost radiotherapy with concurrent and consolidated oral S-1 chemotherapy vs radiotherapy alone for patients aged 70 years and older with inoperable esophageal squamous cell carcinoma.
This secondary analysis examines the local-regional failure, distant failure, disease-free survival, and overall survival in patients with esophageal cancer who underwent definitive chemoradiotherapy during NRG Oncology randomized clinical trials.
This cohort study examines the association of esophagogastric cancer with bariatric surgery in a large national cohort.
This meta-analysis examines whether immunotherapy confers a survival benefit for patients with advanced esophageal squamous cell carcinoma and low expression of PD-L1.
This diagnostic study establishes and validates esophageal squamous cell cancer prediction models for the follow-up stage of esophageal cancer screening and optimization of the esophageal cancer screening program.
This cohort study explores the expression pattern and association of sialic acid–binding immunoglobulin-like lectin 15 (Siglec-15) with outcomes among patients with esophageal squamous cell carcinoma (ESCC) who received neoadjuvant chemoradiotherapy.
This cohort study examines the incidence of esophageal squamous cell carcinoma (ESCC) and the use of surveillance endoscopy in patients with low-grade intraepithelial neoplasia in China.
This validation study evaluates whether diffuse reflectance spectroscopy on gastric and esophageal cancer specimens can differentiate tissue types and provide real-time feedback to the operator.
This systematic review and meta-analysis examines recent or ongoing nonrandomized clinical trials involving patients with esophageal cancer who received immune checkpoint inhibitors with or without other therapies.
This cohort study analyzes data collected prospectively for 3 benign foregut procedures performed in 19 medical centers to determine whether same-day home recovery is feasible, safe, and effective.
This systematic review and meta-analysis examines the predictive value of tissue-based PD-L1 status compared with other variables for ICI benefit among 17 randomized clinical trials including 11 166 patients with advanced gastroesophageal cancer.
This cohort study characterizes the clinical and genomic features of patients with brain metastasis from gastroesophageal adenocarcinoma and evaluates the associations of surgical resection and radiotherapy use with survival.
This review summarizes the current evidence regarding diagnosis and management of Barrett esophagus, including how to evaluate patients for Barrett esophagus, the association with gastroesophageal reflux disease, and progression to esophageal adenocarcinoma.
This follow-up of a randomized clinical trial evaluates long-term weight loss and remission of obesity-related conditions 10 years after laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass.
This randomized clinical trial investigates the efficacy of trastuzumab and PD-1 inhibitor with CTLA-4 inhibitor or FOLFOX in first-line treatment of advanced ERBB2-positive esophagogastric adenocarcinoma.
This cohort study investigates the use, safety, and costs associated with the use of per-oral endoscopic myotomy for achalasia in the US.
Customize your JAMA Network experience by selecting one or more topics from the list below.